Medical Science
| Open Access |
DOI: Prognostic Significance Of Endothelin-1 In Patients With Unstable Angina
Sabirova Azizaxon Dilshodovna , Tashkent State Medical University Multidisciplinary Clinic, Department of Cardiology. Cardiologist, Tashkent, 100109, Uzbekistan Abdashimov Zafar Bakhtiyarovich , Deputy Chief Medical Officer, TDTU Multidisciplinary Clinic, Clinical Pharmacologist, Tashkent, 100109, Uzbekistan Nurillayeva Nargiza Mukhtarkhanovna , MD, PhD, Professor, Department of Internal Diseases in Family Medicine No. 1 and Fundamentals of Preventive Medicine, Tashkent State Medical University, Tashkent, 100109, UzbekistanAbstract
Background: Endothelial dysfunction is a key pathophysiological mechanism underlying acute coronary syndromes. Endothelin-1 (ET-1), one of the most potent endogenous vasoconstrictors, plays a central role in coronary vasomotor dysregulation, inflammation, oxidative stress, and plaque instability. Despite growing interest in endothelin-mediated pathways, the clinical and prognostic significance of ET-1 in unstable angina remains insufficiently characterized, particularly in Central Asian populations. Objective: To investigate serum endothelin-1 levels in patients with unstable angina, to assess their association with clinical severity, ischemic burden, inflammatory activity, and to evaluate their prognostic value during short-term follow-up. Methods: A prospective observational study was conducted between 2024 and 2025 in tertiary cardiology centers in Tashkent, Uzbekistan. A total of 112 patients with unstable angina and 40 apparently healthy controls were enrolled. Serum ET-1 concentrations were measured using enzyme-linked immunosorbent assay. Clinical characteristics, frequency of angina attacks, ambulatory ECG monitoring parameters, and inflammatory markers were analyzed. Patients were followed for early adverse cardiovascular events. Results: Patients with unstable angina exhibited significantly higher ET-1 levels compared with controls (0.78 ± 0.21 vs. 0.26 ± 0.09 fmol/mL, p < 0.001). Elevated ET-1 was associated with increased ischemic burden, recurrent angina episodes, and unfavorable ECG patterns. A strong positive correlation was observed between ET-1 concentration and angina frequency (r = 0.54, p < 0.01). Persistently elevated ET-1 levels were predictive of early adverse cardiovascular outcomes. Conclusion: Endothelin-1 is a sensitive marker of endothelial dysfunction and an independent predictor of disease severity and short-term prognosis in unstable angina. Routine assessment of ET-1 may enhance risk stratification and guide personalized therapeutic strategies in acute coronary syndromes.
Keywords
Endothelin-1, unstable angina, endothelial dysfunction
References
World Health Organization. Cardiovascular diseases (CVDs). Geneva: WHO; 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
Collet JP, Thiele H, Barbato E, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720–3826. doi:10.1093/eurheartj/ehad191
Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868–874. doi:10.1038/nature01323
Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340(2):115–126. doi:10.1056/NEJM199901143400207
Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation. 2005;111(3):363–368. doi:10.1161/01.CIR.0000153339.27064.14
Böhm F, Pernow J. Endothelin-1 and cardiovascular disease. J Intern Med. 2007;261(1):1–20. doi:10.1111/j.1365-2796.2006.01731.x
Dhaun N, Webb DJ. Endothelins in cardiovascular biology and therapeutics. J Am Coll Cardiol. 2019;74(4):557–575. doi:10.1016/j.jacc.2019.05.052
Schiffrin EL. Role of endothelin-1 in hypertension and vascular disease. Hypertension. 2001;37(2):582–587. doi:10.1161/01.HYP.37.2.582
Kinlay S, Behrendt D, Wainstein M, et al. Role of endothelin-1 in coronary vasomotion and ischemia. Circulation. 2001;104(10):1114–1118. doi:10.1161/hc3501.095338
Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Free Radic Biol Med. 2005;39(5):571–580. doi:10.1016/j.freeradbiomed.2005.04.001
Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev. 1994;46(3):325–415.
Barton M. Endothelin and atherosclerosis. Cardiovasc Res. 2016;109(1):1–10. doi:10.1093/cvr/cvv240
Vanhoutte PM, Shimokawa H, Tang EH, Feletou M. Endothelial dysfunction and vascular disease. Eur Heart J. 2009;30(2):139–149. doi:10.1093/eurheartj/ehn578
Galiè N, Manes A, Branzi A. The endothelin system in pulmonary arterial hypertension. Eur Respir J. 2009;33(2):239–252. doi:10.1183/09031936.00082208
Tousoulis D, Kampoli AM, Tentolouris C, Papageorgiou N, Stefanadis C. The role of nitric oxide on endothelial function. Curr Vasc Pharmacol. 2012;10(1):4–18. doi:10.2174/157016112798829760
Downloads
Copyright License
Copyright (c) 2025 Sabirova Azizaxon Dilshodovna, Abdashimov Zafar Bakhtiyarovich, Nurillayeva Nargiza Mukhtarkhanovna
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.